Related Experiment Video
Updated: Aug 24, 2025

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
A Cantú syndrome mutation produces dual effects on KATP channels by disrupting ankyrin B regulation
Teresa Crespo-García1,2, Marcos Rubio-Alarcón1,2, Anabel Cámara-Checa1,2
1Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Instituto de Investigación Gregorio Marañón, Madrid, Spain.
Abstract:
ATP-sensitive potassium (KATP) channels composed of Kir6.x and sulfonylurea receptor (SURs) subunits couple cellular metabolism to electrical activity. Cantú syndrome (CS) is a rare disease caused by mutations in the genes encoding Kir6.1 (KCNJ8) and SUR2A (ABCC9) that produce KATP channel hyperactivity due to a reduced channel block by physiological ATP concentrations. We functionally characterized the p.S1054Y SUR2A mutation identified in two CS carriers, who exhibited a mild phenotype although the mutation was predicted as highly pathogenic. We recorded macroscopic and single-channel currents in CHO and HEK-293 cells and measured the membrane expression of the channel subunits by biotinylation assays in HEK-293 cells. The mutation increased basal whole-cell current density and at the single-channel level, it augmented opening frequency, slope conductance, and open probability (Po), and promoted the appearance of multiple conductance levels. p.S1054Y also reduced Kir6.2 and SUR2A expression specifically at the membrane. Overexpression of ankyrin B (AnkB) prevented these gain- and loss-of-function effects, as well as the p.S1054Y-induced reduction of ATP inhibition of currents measured in inside-out macropatches. Yeast two-hybrid assays suggested that SUR2A WT and AnkB interact, while p.S1054Y interaction with AnkB is decreased. The p.E322K Kir6.2 mutation, which prevents AnkB binding to Kir6.2, produced similar biophysical alterations than p.S1054Y. Our results are the first demonstration of a CS mutation whose functional consequences involve the disruption of AnkB effects on KATP channels providing a novel mechanism by which CS mutations can reduce ATP block. Furthermore, they may help explain the mild phenotype associated with this mutation.
Insights
A Cantú syndrome mutation (p.S1054Y SUR2A) disrupts ankyrin B interactions, leading to altered ATP-sensitive potassium (KATP) channel function and explaining mild disease phenotypes.
Area of Science:
- Molecular Biology
- Cardiovascular Physiology
- Channelopathies
Background:
- ATP-sensitive potassium (KATP) channels, formed by Kir6.x and sulfonylurea receptor (SUR) subunits, link cellular metabolism to electrical activity.
- Cantú syndrome (CS) arises from KATP channel hyperactivity caused by mutations in KCNJ8 (Kir6.1) or ABCC9 (SUR2A), reducing ATP's inhibitory effect.
Purpose of the Study:
- To functionally characterize the p.S1054Y SUR2A mutation found in mild CS cases.
- To investigate the role of ankyrin B (AnkB) in mediating the effects of this mutation on KATP channel function.
Main Methods:
- Macroscopic and single-channel current recordings in heterologous expression systems (CHO, HEK-293 cells).
- Biotinylation assays to measure membrane expression of channel subunits.
- Yeast two-hybrid assays to assess protein-protein interactions.
- Patch-clamp electrophysiology (inside-out macropatches) to study ATP inhibition.
Main Results:
- The p.S1054Y mutation increased KATP channel current density, altered single-channel properties (increased opening frequency, conductance, Po), and reduced membrane expression of Kir6.2 and SUR2A.
- Ankyrin B overexpression reversed these functional and expression changes, indicating a protective role.
- The mutation impaired the interaction between SUR2A and AnkB, similar to a known AnkB-binding deficient Kir6.2 mutation (p.E322K).
Conclusions:
- The p.S1054Y CS mutation disrupts KATP channel function by interfering with AnkB binding and effects, representing a novel mechanism for reduced ATP block.
- This disruption of the AnkB-SUR2A interaction may explain the milder clinical phenotype observed in carriers of this specific mutation.
More Related Videos
12:47Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease
Published on: February 3, 2012
12:48Measuring Cation Transport by Na,K- and H,K-ATPase in Xenopus Oocytes by Atomic Absorption Spectrophotometry: An Alternative to Radioisotope Assays
Published on: February 19, 2013
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Anaphase Promoting Complex
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
ATP Synthase: Mechanism
Destabilization of Microtubules
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...